Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Ambrogi Michael J.. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Ambrogi Michael J. har rapporterat innehav eller affärer i följande företag:
| Värdepapper | Titel | Senaste rapporterade innehav |
|---|---|---|
| US:NVCR / NovoCure Limited | Chief Operating Officer | 67 586 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Ambrogi Michael J.. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Ambrogi Michael J. som avslöjats för Securities Exchange Commission (SEC).
| Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −30 772 | 67 586 | −31,29 | ||||
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −3 774 | 0 | −100,00 | ||||
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −8 426 | 0 | −100,00 | ||||
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −17 175 | 220 867 | −7,22 | 67,39 | −1 157 475 | 14 884 890 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −12 217 | 238 042 | −4,88 | 66,66 | −814 336 | 15 866 928 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −1 380 | 250 259 | −0,55 | 65,49 | −90 375 | 16 389 212 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 30 772 | 251 639 | 13,93 | 21,15 | 650 828 | 5 322 165 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −2 623 | 220 867 | −1,17 | 67,28 | −176 470 | 14 859 490 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −1 151 | 223 490 | −0,51 | 66,50 | −76 539 | 14 861 638 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 3 774 | 224 641 | 1,71 | 11,46 | 43 250 | 2 574 386 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −3 798 | 220 867 | −1,69 | 67,48 | −256 274 | 14 903 222 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −4 228 | 224 665 | −1,85 | 66,77 | −282 287 | 14 999 983 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −400 | 228 893 | −0,17 | 65,52 | −26 210 | 14 998 214 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 8 426 | 229 293 | 3,81 | 11,46 | 96 562 | 2 627 698 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −3 021 | 98 358 | −2,98 | ||||
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −300 | 8 426 | −3,44 | ||||
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −3 021 | 220 867 | −1,35 | 65,06 | −196 552 | 14 370 049 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 3 021 | 223 888 | 1,37 | 21,15 | 63 894 | 4 735 231 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −300 | 220 867 | −0,14 | 65,07 | −19 520 | 14 371 153 | |
| 2020-07-23 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 300 | 221 167 | 0,14 | 11,46 | 3 438 | 2 534 574 | |
| 2020-04-15 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −35 745 | 44 514 | −44,54 | ||||
| 2020-04-15 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −377 | 220 867 | −0,17 | 71,75 | −27 051 | 15 847 870 | |
| 2020-04-15 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −27 142 | 221 244 | −10,93 | 70,99 | −1 926 919 | 15 706 997 | |
| 2020-04-15 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 35 745 | 256 612 | 16,18 | 7,15 | 255 577 | 1 834 776 | |
| 2020-04-15 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −22 755 | 80 259 | −22,09 | ||||
| 2020-04-15 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −8 226 | 248 386 | −3,21 | 70,18 | −577 317 | 17 432 226 | |
| 2020-04-15 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −22 755 | 220 867 | −9,34 | 69,01 | −1 570 277 | 15 241 590 | |
| 2020-04-15 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 22 755 | 243 622 | 10,30 | 7,15 | 162 698 | 1 741 897 | |
| 2020-03-10 |
|
4 | NVCR |
NovoCure Ltd
Restricted Share Units |
S - Sale | −2 274 | 220 867 | −1,02 | 69,53 | −158 120 | 15 357 766 | |
| 2020-03-05 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 27 794 | 27 794 | |||||
| 2020-03-05 |
|
4 | NVCR |
NovoCure Ltd
Restricted Share Units |
A - Award | 14 415 | 223 141 | 6,91 | ||||
| 2020-03-02 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −2 673 | 208 726 | −1,26 | 72,22 | −193 031 | 15 073 148 | |
| 2020-03-02 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | −6 173 | 6 172 | −50,00 | ||||
| 2020-03-02 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 6 173 | 211 399 | 3,01 | 79,45 | 490 445 | 16 795 651 | |
| 2020-02-26 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −11 647 | 205 226 | −5,37 | 81,16 | −945 224 | 16 655 321 | |
| 2020-02-26 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | −31 199 | 0 | −100,00 | ||||
| 2020-02-26 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 31 199 | 216 873 | 16,80 | 88,26 | 2 753 624 | 19 141 211 | |
| 2019-11-06 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −33 793 | 96 651 | −25,91 | ||||
| 2019-11-06 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −36 957 | 0 | −100,00 | ||||
| 2019-11-06 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −10 069 | 0 | −100,00 | ||||
| 2019-11-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −33 793 | 185 674 | −15,40 | 79,00 | −2 669 647 | 14 668 246 |
| 2019-11-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 33 793 | 219 467 | 18,20 | 21,15 | 714 722 | 4 641 727 |
| 2019-11-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −36 957 | 185 674 | −16,60 | 79,00 | −2 919 603 | 14 668 246 |
| 2019-11-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 36 957 | 222 631 | 19,90 | 22,00 | 813 054 | 4 897 882 |
| 2019-11-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −10 069 | 185 674 | −5,14 | 79,00 | −795 451 | 14 668 246 |
| 2019-11-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 10 069 | 195 743 | 5,42 | 14,37 | 144 692 | 2 812 827 |
| 2019-06-21 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −110 868 | 36 957 | −75,00 | ||||
| 2019-06-21 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | X | −110 868 | 185 674 | −37,39 | 60,00 | −6 652 080 | 11 140 440 |
| 2019-06-21 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 110 868 | 296 542 | 59,71 | 22,00 | 2 439 096 | 6 523 924 |
| 2019-06-10 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −5 999 | 103 014 | −5,50 | ||||
| 2019-06-10 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −5 999 | 185 674 | −3,13 | 54,79 | −328 661 | 10 172 336 | |
| 2019-06-10 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 5 999 | 191 673 | 3,23 | 7,15 | 42 893 | 1 370 462 |
| 2019-06-06 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −17 500 | 109 013 | −13,83 | ||||
| 2019-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −17 500 | 185 674 | −8,61 | 54,14 | −947 485 | 10 052 762 | |
| 2019-06-06 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 17 500 | 203 174 | 9,43 | 7,15 | 125 125 | 1 452 694 |
| 2019-06-05 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −17 500 | 126 513 | −12,15 | ||||
| 2019-06-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −200 | 185 674 | −0,11 | 53,79 | −10 758 | 9 987 404 | |
| 2019-06-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −17 300 | 185 874 | −8,51 | 53,11 | −918 855 | 9 872 326 | |
| 2019-06-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 17 500 | 203 174 | 9,43 | 7,15 | 125 125 | 1 452 694 |
| 2019-06-05 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −17 500 | 144 013 | −10,84 | ||||
| 2019-06-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −800 | 185 674 | −0,43 | 52,70 | −42 158 | 9 784 648 | |
| 2019-06-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −16 700 | 186 474 | −8,22 | 52,09 | −869 970 | 9 714 177 | |
| 2019-06-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 17 500 | 203 174 | 9,43 | 7,15 | 125 125 | 1 452 694 |
| 2019-05-10 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 20 000 | 20 000 | |||||
| 2019-05-10 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 91 515 | 91 515 | |||||
| 2019-04-03 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −15 516 | 0 | −100,00 | ||||
| 2019-04-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −132 | 185 674 | −0,07 | 47,83 | −6 314 | 8 881 344 | |
| 2019-04-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −15 384 | 185 806 | −7,65 | 47,24 | −726 725 | 8 777 290 | |
| 2019-04-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 15 516 | 201 190 | 8,36 | 14,37 | 222 965 | 2 891 100 |
| 2019-04-03 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −12 500 | 3 774 | −76,81 | ||||
| 2019-04-03 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −21 875 | 15 516 | −58,50 | ||||
| 2019-04-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −1 298 | 185 674 | −0,69 | 48,09 | −62 418 | 8 928 691 | |
| 2019-04-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −11 202 | 186 972 | −5,65 | 47,39 | −530 896 | 8 861 164 | |
| 2019-04-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 12 500 | 198 174 | 6,73 | 11,46 | 143 250 | 2 271 074 |
| 2019-04-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −1 600 | 185 674 | −0,85 | 48,07 | −76 915 | 8 925 721 | |
| 2019-04-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −20 275 | 187 274 | −9,77 | 47,29 | −958 784 | 8 856 000 | |
| 2019-04-03 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 21 875 | 207 549 | 11,78 | 14,37 | 314 344 | 2 982 479 |
| 2019-03-26 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
A - Award | 29 969 | 29 969 | |||||
| 2019-03-26 |
|
4 | NVCR |
NovoCure Ltd
Restricted Share Units |
A - Award | 16 369 | 185 674 | 9,67 | ||||
| 2019-03-01 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −2 397 | 169 305 | −1,40 | 53,68 | −128 671 | 9 088 292 | |
| 2019-03-01 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | −6 174 | 12 345 | −33,34 | ||||
| 2019-03-01 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 6 174 | 171 702 | 3,73 | 52,90 | 326 605 | 9 083 036 | |
| 2019-02-26 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −12 230 | 165 528 | −6,88 | 53,63 | −655 870 | 8 876 936 | |
| 2019-02-26 |
|
4 | NVCR |
NovoCure Ltd
Restricted Stock Units |
M - Exercise | −31 200 | 31 199 | −50,00 | ||||
| 2019-02-26 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 31 200 | 177 758 | 21,29 | 53,38 | 1 665 456 | 9 488 722 | |
| 2019-02-05 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −21 000 | 161 513 | −11,51 | ||||
| 2019-02-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −21 000 | 146 558 | −12,53 | 49,53 | −1 040 193 | 7 259 457 | |
| 2019-02-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 21 000 | 167 558 | 14,33 | 7,15 | 150 150 | 1 198 040 |
| 2019-02-05 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −37 500 | 182 513 | −17,04 | ||||
| 2019-02-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −9 840 | 146 558 | −6,29 | 49,51 | −487 159 | 7 255 793 | |
| 2019-02-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −27 660 | 156 398 | −15,03 | 48,86 | −1 351 495 | 7 641 763 | |
| 2019-02-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | X | 37 500 | 184 058 | 25,59 | 7,15 | 268 125 | 1 316 015 |
| 2019-01-14 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −54 930 | 37 391 | −59,50 | ||||
| 2019-01-14 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −34 050 | 146 558 | −18,85 | 41,14 | −1 400 817 | 6 029 396 | |
| 2019-01-14 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −20 880 | 180 608 | −10,36 | 40,47 | −844 993 | 7 309 025 | |
| 2019-01-14 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 54 930 | 201 488 | 37,48 | 14,37 | 789 344 | 2 895 383 | |
| 2019-01-11 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | 25 000 | 16 274 | −286,50 | ||||
| 2019-01-11 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | 75 000 | 92 321 | 433,00 | ||||
| 2019-01-11 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −25 000 | 146 558 | −14,57 | 40,00 | −1 000 000 | 5 862 320 | |
| 2019-01-11 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 25 000 | 171 558 | 17,06 | 11,46 | 286 500 | 1 966 055 | |
| 2019-01-11 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −75 000 | 146 558 | −33,85 | 40,00 | −3 000 000 | 5 862 320 | |
| 2019-01-11 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 75 000 | 221 558 | 51,17 | 14,37 | 1 077 750 | 3 183 788 | |
| 2018-07-05 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | 29 565 | 0 | −100,00 | ||||
| 2018-07-05 |
|
4 | NVCR |
NovoCure Ltd
Options to Buy Ordinary Shares |
M - Exercise | 27 825 | 0 | −100,00 | ||||
| 2018-07-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
S - Sale | −57 390 | 146 558 | −28,14 | 31,48 | −1 806 637 | 4 613 646 | |
| 2018-07-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 29 565 | 203 948 | 16,95 | 7,48 | 221 146 | 1 525 531 | |
| 2018-07-05 |
|
4 | NVCR |
NovoCure Ltd
Ordinary Shares |
M - Exercise | 27 825 | 174 383 | 18,99 | 7,03 | 195 610 | 1 225 912 | |
| 2018-05-03 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −11 305 | 3 890 | −74,40 | ||||
| 2018-05-03 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −20 000 | 15 195 | −56,83 | ||||
| 2018-05-03 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −20 000 | 15 195 | −56,83 | ||||
| 2018-05-03 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −8 695 | 20 000 | −30,30 | ||||
| 2018-05-03 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −60 000 | 146 558 | −29,05 | 27,40 | −1 644 000 | 4 015 689 | |
| 2018-05-03 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | X | −31 305 | 206 558 | −13,16 | 7,03 | −220 074 | 1 452 103 |
| 2018-05-03 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | X | 28 695 | 175 253 | 19,58 | 3,44 | 98 711 | 602 870 |
| 2018-04-30 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −20 000 | 28 695 | −41,07 | ||||
| 2018-04-30 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −328 | 146 558 | −0,22 | 26,05 | −8 544 | 3 817 836 |
| 2018-04-30 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −4 300 | 146 886 | −2,84 | 26,02 | −111 908 | 3 822 708 |
| 2018-04-30 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −1 800 | 151 186 | −1,18 | 26,01 | −46 818 | 3 932 348 |
| 2018-04-30 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −13 572 | 152 986 | −8,15 | 26,00 | −352 872 | 3 977 636 |
| 2018-04-30 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | X | 20 000 | 166 558 | 13,65 | 3,44 | 68 800 | 572 960 |
| 2018-04-19 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −20 000 | 48 695 | −29,11 | ||||
| 2018-04-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −20 000 | 146 558 | −12,01 | 24,00 | −480 000 | 3 517 392 |
| 2018-04-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | X | 20 000 | 166 558 | 13,65 | 3,44 | 68 800 | 572 960 |
| 2018-04-19 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −20 000 | 68 695 | −22,55 | ||||
| 2018-04-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −545 | 146 558 | −0,37 | 22,21 | −12 104 | 3 255 053 |
| 2018-04-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −1 255 | 147 103 | −0,85 | 22,10 | −27 741 | 3 251 565 |
| 2018-04-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −2 000 | 148 358 | −1,33 | 22,10 | −44 200 | 3 278 712 |
| 2018-04-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −15 900 | 150 358 | −9,56 | 22,05 | −350 595 | 3 315 394 |
| 2018-04-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −300 | 166 258 | −0,18 | 22,00 | −6 600 | 3 657 676 |
| 2018-04-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | X | 20 000 | 166 558 | 13,65 | 3,44 | 68 800 | 572 960 |
| 2018-03-20 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | 49 728 | 0 | −100,00 | ||||
| 2018-03-20 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 49 728 | 146 558 | 51,36 | 0,23 | 11 437 | 33 708 | |
| 2018-03-01 |
|
4 | NVCR |
Novocure Ltd
Restricted Stock Unit |
A - Award | 18 519 | 18 519 | |||||
| 2018-03-01 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 135 172 | 135 172 | |||||
| 2018-02-26 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −8 458 | 96 830 | −8,03 | 19,83 | −167 705 | 1 919 945 | |
| 2018-02-26 |
|
4 | NVCR |
Novocure Ltd
Restricted Stock Units |
M - Exercise | −31 201 | 62 399 | −33,33 | ||||
| 2018-02-26 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 31 201 | 105 288 | 42,11 | 21,55 | 672 382 | 2 268 956 | |
| 2018-02-08 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −50 000 | 74 087 | −40,29 | ||||
| 2018-02-08 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 50 000 | 74 087 | 207,58 | 0,23 | 11 500 | 17 040 | |
| 2017-11-06 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −900 | 24 087 | −3,60 | 22,00 | −19 800 | 529 914 |
| 2017-11-06 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −300 | 24 987 | −1,19 | 22,00 | −6 600 | 549 714 |
| 2017-11-02 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −24 227 | 25 287 | −48,93 | 22,01 | −533 164 | 556 491 | |
| 2017-11-02 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | X | −100 | 49 514 | −0,20 | 22,00 | −2 200 | 1 089 308 |
| 2017-09-27 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
D - Sale to Issuer | −3 200 | 49 614 | −6,06 | 22,05 | −70 555 | 1 093 909 | |
| 2017-09-21 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
D - Sale to Issuer | X | −3 200 | 52 814 | −5,71 | 22,00 | −70 400 | 1 161 908 |
| 2017-09-15 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
D - Sale to Issuer | −1 746 | 56 014 | −3,02 | 22,00 | −38 417 | 1 232 470 | |
| 2017-09-15 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
D - Sale to Issuer | −76 327 | 57 760 | −56,92 | 22,02 | −1 680 522 | 1 271 725 | |
| 2017-07-07 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
A - Award | 1 395 | 134 087 | 1,05 | 6,67 | 9 309 | 894 763 | |
| 2017-02-24 |
|
4 | NVCR |
Novocure Ltd
Restricted Stock Unit |
A - Award | 93 600 | 93 600 | |||||
| 2017-02-24 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 234 000 | 234 000 | |||||
| 2017-01-06 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
A - Award | 1 108 | 132 692 | 0,84 | 6,67 | 7 394 | 885 454 | |
| 2016-12-22 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −7 500 | 131 584 | −5,39 | 8,09 | −60 695 | 1 064 870 | |
| 2016-12-22 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −20 000 | 139 084 | −12,57 | 8,33 | −166 608 | 1 158 625 | |
| 2016-12-21 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −20 000 | 159 084 | −11,17 | 8,62 | −172 476 | 1 371 909 | |
| 2016-12-21 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −20 000 | 179 084 | −10,05 | 8,76 | −175 178 | 1 568 579 | |
| 2016-12-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −20 000 | 199 084 | −9,13 | 8,71 | −174 270 | 1 734 718 | |
| 2016-12-19 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −20 000 | 219 084 | −8,37 | 9,14 | −182 858 | 2 003 063 | |
| 2016-12-15 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −20 000 | 239 084 | −7,72 | 8,96 | −179 294 | 2 143 316 | |
| 2016-12-15 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −20 000 | 259 084 | −7,17 | 8,98 | −179 688 | 2 327 714 | |
| 2016-12-13 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −10 000 | 279 084 | −3,46 | 9,04 | −90 442 | 2 524 092 | |
| 2016-12-13 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −5 000 | 289 084 | −1,70 | 8,93 | −44 668 | 2 582 561 | |
| 2016-12-09 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −5 000 | 294 084 | −1,67 | 8,37 | −41 832 | 2 460 395 | |
| 2016-12-09 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −5 000 | 299 084 | −1,64 | 8,24 | −41 175 | 2 462 957 | |
| 2016-12-07 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −5 000 | 304 084 | −1,62 | 8,22 | −41 110 | 2 500 179 | |
| 2016-12-07 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −5 000 | 309 084 | −1,59 | 8,25 | −41 245 | 2 549 634 | |
| 2016-06-10 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −10 000 | 314 084 | −3,09 | 12,27 | −122 700 | 3 853 811 | |
| 2016-06-10 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
S - Sale | −10 000 | 324 084 | −2,99 | 12,21 | −122 100 | 3 957 066 | |
| 2016-02-26 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 50 000 | 50 000 | |||||
| 2016-01-05 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −332 984 | 0 | −100,00 | ||||
| 2016-01-05 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 332 984 | 334 084 | 30 271,27 | 0,17 | 56 607 | 56 794 | |
| 2015-12-22 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
M - Exercise | −1 100 | 332 984 | −0,33 | ||||
| 2015-12-22 |
|
4 | NVCR |
Novocure Ltd
Ordinary Shares |
M - Exercise | 1 100 | 1 100 | 0,17 | 187 | 187 | ||
| 2015-10-05 |
|
4 | NVCR |
Novocure Ltd
Options to Buy Ordinary Shares |
A - Award | 147 825 | 147 825 |